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Abstract
Background: Timely reporting of infectious disease cases to public health authorities is essential to effective public
health response. To evaluate the timeliness of reporting to the Dutch Municipal Health Services (MHS), we used as
quantitative measures the intervals between onset of symptoms and MHS notification, and between laboratory
diagnosis and notification with regard to six notifiable diseases.
Methods: We retrieved reporting data from June 2003 to December 2008 from the Dutch national notification
system for shigellosis, EHEC/STEC infection, typhoid fever, measles, meningococcal disease, and hepatitis A virus
(HAV) infection. For each disease, median intervals between date of onset and MHS notification were calculated
and compared with the median incubation period. The median interval between date of laboratory diagnosis and
MHS notification was similarly analysed. For the year 2008, we also investigated whether timeliness is improved by
MHS agreements with physicians and laboratories that allow direct laboratory reporting. Finally, we investigated
whether reports made by post, fax, or e-mail were more timely.
Results: The percentage of infectious diseases reported within one incubation period varied widely, between 0.4%
for shigellosis and 90.3% for HAV infection. Not reported within two incubation periods were 97.1% of shigellosis
cases, 76.2% of cases of EHEC/STEC infection, 13.3% of meningococcosis cases, 15.7% of measles cases, and 29.7%
of typhoid fever cases. A substantial percentage of infectious disease cases was reported more than three days
after laboratory diagnosis, varying between 12% for meningococcosis and 42% for shigellosis. MHS which had
agreements with physicians and laboratories showed a significantly shorter notification time compared to MHS
without such agreements.
Conclusions: Over the study period, many cases of the six notifiable diseases were not reported within two
incubation periods, and many were reported more than three days after laboratory diagnosis. An increase in direct
laboratory reporting of diagnoses to MHS would improve timeliness, as would the use of fax rather than post or e-
mail. Automated reporting systems have to be explored in the Netherlands. Development of standardised and
improved measures for timeliness is needed.
Background
Accurate communicable disease surveillance systems are
essential to initiate and sustain effective public health
response and control measures. Efforts to improve com-
pleteness and timeliness of surveillance data on infec-
tious diseases must therefore be part of a continuous
process to improve the quality of surveillance systems in
order to minimise further spread of disease [1-3].
Timeliness in reporting is crucial in preventing sec-
ondary cases and outbreaks of infectious diseases. Delays
in the notification process can occur in patients going to
their general practitioner or in reporting the laboratory
diagnosis to the MHS. According to guidelines, pro-
duced by the United States Centers for Disease Control
and Prevention, timeliness should be periodically evalu-
ated for each specific surveillance step of each notifiable
disease [4]. Nonetheless, a quantitative measure of time-
liness of surveillance systems has not been standardised,
and study methods vary, often comparing conventional
paper-based systems to electronic systems [5,6] or refer-
ring to time limits that differ among countries [7].
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and timeliness are few in number [6-9]. Some surveil-
lance systems did not always record date of symptom
onset of disease; some analysed time intervals that were
omitted by others, such as the period between hospital
admission and notification date [9,10].
The incubation period of a disease, as a proxy for its
period of transmissibility, has been used as a quantita-
tive measure to evaluate timeliness of reporting [6,8].
This is justified, as it relates to the time before second-
ary cases may occur and is also the most effective time
for prevention and control measures, such as active or
passive immunisation of close contacts or the use of
post-exposure prophylaxis [6,11]. In addition, outbreaks
are often assumed to have ended after two incubation
periods have passed since the end of the period of infec-
tiousness of the last case.
In the Netherlands, physicians are legally obliged to
report laboratory-confirmed diagnoses of certain com-
municable diseases to the local Municipal Health Service
(MHS). They should report within one day or within
three days if a weekend intervenes. In turn, the MHS
reports overnight to the National Institute for Public
Health and the Environment (RIVM), using a web-based
application [5].
The introduction of mandatory reporting by labora-
tories as well as by physicians could potentially improve
timeliness [12-15]. During our study period, this hypoth-
esis was investigated by examining physician-laboratory-
MHS agreements that authorised direct reporting by
one or more local laboratories.
Timeliness might also be influenced by the method of
reporting. Traditionally, physicians used paper “report
cards” provided by the Inspectorate of Healthcare as a
postal notification form, but these are little used nowa-
days. A minority of laboratories and physicians use elec-
tronic(e)-mail for reporting to the MHS; the precise
proportion is unknown.
In this study we performed a quantitative analysis of
the timeliness of infectious disease reporting in the
Netherlands for six diseases. The intervals between
onset of symptoms and MHS notification, and between
laboratory diagnosis and notification, were used as
quantitative measures of timeliness. These intervals can
be influenced in different ways. Public health authorities
can raise alertness of patients and physicians with regard
to certain diseases so that laboratory tests are requested
at an early stage. After laboratory confirmation of diag-
noses, reporting is most influenced by delays in commu-
nication. Such delays should be avoided, and so this
interval is separately analysed in our study.
We report here serious reporting delays per disease,
expressed in the percentage of notifications occurring
within one and two incubation periods.
We relate timeliness to the existence of physician-
laboratory-MHS agreements, different methods of
reporting (post, fax, telephone, e-mail), and the number
of notifications using “report cards.”
Methods
We selected notifiable infectious diseases based on their
epidemic potential, number of reported cases, use of
laboratory confirmation, and available literature for
comparisons. As a result, reports for six infectious dis-
eases were studied: shigellosis, entero-haemorrhagic or
Shiga-like toxin-producing E. coli (EHEC/STEC) infec-
tion, typhoid fever, measles, meningococcosis, and hepa-
titis A virus (HAV) infection. The criteria for reporting
these infectious diseases in the Netherlands are the clin-
ical criteria in combination with the confirmation of the
diagnosis by laboratory testing. Notifications from June
2003 to December 2008 were retrieved from the Dutch
national database, including date of symptom onset,
date of laboratory-confirmed diagnosis, and date of
reporting to the Municipal Health Service (MHS).
For each case, we determined the intervals between
the zero timepoint of symptom onset (T0) and MHS
notification (T5), and between laboratory diagnosis (T2)
and MHS notification (T5). As shown in Figure 1, the
interval between timepoints onset (T0) and notification
(T5) was defined as the period from onset of symptoms
until notification (Po); the interval between timepoints
diagnosis (T2) and notification (T5) was defined as the
period from laboratory diagnosis until notification (Pd).
We then determined the median of the distributions of
Po and Pd for each of the six diseases.
For comparison with the notification data, we used the
midpoint of the range of the incubation period for each
disease, as it is defined in the literature and in the
national guidelines of the RIVM in the Netherlands [16].
Figure 1 Time-points (T) and intervals (P) in the notification
process. GP = general practitioner; Po = period between symptom
onset and MHS notification; Pd = period between laboratory
diagnosis and MHS notification; MHS = Municipal Health Service;
RIVM = National Institute for Public Health and the Environment.
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disease occurring within one and two incubation periods
respectively (in the context of preventing the occurrence
of tertiary cases).
There is international consensus that for HAV infec-
tions and measles, the period of infectiousness starts
before onset of symptomatic disease. The incubation per-
iod (IP) for these diseases is thus less valid as a proxy for
the period in which public health measures are most
effective. More adequate for these diseases is the latent
period (LP), defined as the period between being infected
and becoming infectious for others [17]. Reporting of the
index case should preferably occur before the onset of
infectiousness in a possible secondary case. As a second-
ary case can be infected before symptom onset in the
index patient, this time interval must be subtracted from
the LP. We therefore defined a corrected time interval
(Ic) as the interval from symptom onset in the index case
to the start of infectiousness in one or more secondary
cases. As shown in Figure 2: Ic (interval corrected) = LP
(latent period) - × (period of infectiousness in index
patient preceding symptom onset)
For HAV infections, × is about seven days; for
measles, × is 1-2 days. Thus the Ic for HAV infection is
14 days, given the LP of 21 days. The Ic for measles is
seven days, given the LP of 8-9 days.
Of the six diseases under study, shigellosis and HAV
infection were used in the calculation of distribution
means of Po and Pd per year, in order to identify possi-
ble trends or changes over the years.
The percentage of notifications occurring more than
three days after laboratory diagnosis was calculated per
disease. We devised a hypothetical scenario with an
interval Pd of zero to demonstrate the improvement
made possible by immediate reporting (on the day of
laboratory diagnosis), using fax, telephone, or e-mail.
All MHS (n = 31) in the Netherlands participated and
were sent a questionnaire regarding timeliness and
methods of reporting hepatitis B virus (HBV) infection
in the year 2008. This disease was chosen because,
unlike many of the other six, it is reported frequently
enough over the years, that data could be expected from
all MHS in all parts of the country.
The questionnaire asked whether physician-laboratory-
MHS agreements were in place to allow direct reporting
of cases of HBV infections by laboratories. It inquired
about methods of reporting (post/fax/phone/e-mail) and
the numbers of “report cards” received by post each
week. The MHS respondents whose questionnaires
mentioned experience with direct laboratory reporting
by e-mail were interviewed by telephone about the num-
ber of these reports, the speed of reporting and the
security of their inhouse electronic mail system.
All analyses were performed in SPSS version 17. Sta-
tistical analysis was performed using Independent Sam-
ples T-test and One-Way analysis of variance (One-Way
ANOVA, post hoc Multiple Comparisons).
Results
Time intervals Po and Pd
In the study period we analysed 1910 reports on shi-
gellosis, 432 reports on EHEC/STEC infection, 1263
reports on meningococcosis, 134 reports on measles,
166 reports on typhoid fever and 1518 reports on
HAV infection. Some reports had missing or incorrect
data for the onset of symptoms timepoint and were
therefore excluded. The median period from onset
until notification (Po) varied between three days for
meningococcosis to 16 days for typhoid fever
(Table 1). When comparing thed i s e a s e - s p e c i f i ci n c u -
bation periods, the median intervals for shigellosis,
EHEC/STEC infection, and typhoid fever exceeded the
midpoints of the incubation periods by several days,
whereas median delays of meningococcosis and
measles were nearly equal to the incubation periods.
The percentage of notifications that occurred within
one incubation period varied widely, between 0.4% for
shigellosis and 90.3% for HAV infection. Not reported
within two incubation periods were 97.1% of shigellosis
cases, 76.2% of cases of EHEC/STEC infection, 13.3%
of meningococcosis cases, 15.7% of measles cases, and
29.7% of typhoid fever cases.
Figure 2 Ic (interval corrected) = LP (latent period) - × (period
of infectiousness before disease onset, index patient).
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HAV infections, only 2.8% of cases of HAV infection
were not reported within two incubation periods.
However, having corrected for the period of infec-
tiousness before disease onset (Ic), the percentage of
HAV infection notifications within one and two cor-
rected intervals was substantially lower, with 71.4% of
cases reported within one Ic (Table 2). Likewise for
measles cases, the percentage reported within one Ic
was lower (48.5%) than reported within one incuba-
tion period (67.2%).
For all six diseases, the median distribution of the per-
iod from diagnosis until notification (Pd) was between
zero and three days, but a substantial percentage of
notifications occurred more than three days after diag-
nosis, varying between 12% for meningococcosis and
42% for shigellosis. Assuming a Pd of zero (i.e. MHS
notification on the same day as laboratory diagnosis),
the median Po decreased by one day for meningococco-
sis and HAV infection to as much as four days for shi-
gellosis, EHEC/STEC infection, and typhoid fever
(underlined figures in italics in Table 1).
For meningococcosis, the percentage of notifications
occurring within one incubation period would be 14%
higher if notification were to take place on the day of
laboratory diagnosis. For shigellosis and EHEC/STEC
infections, the improvement was likewise substantial
(5.5% and 8.3% within one incubation period and 10%
and 19.4% within two incubation periods). However, the
overall percentage of cases reported within one incuba-
tion period remained low, at 5.9% and 10.6%,
respectively.
Time trends
For shigellosis and HAV infection, the mean Pd
decreased by one day from 2003 and 2004 to 2008, the
period of our study. For HAV infection this decrease is
not statistically significant. The mean Po for shigellosis
and HAV infections however, showed no clear time-
trend over the years (Table 3).
Notification procedures
All 31 MHS in the Netherlands returned the question-
naire. Of these, 25 MHS had agreements with physicians
Table 1 Reporting time interval from symptom onset and from diagnosis until notification (Po and Pd) for infectious
disease notifications in relation to the incubation period and in relation to the time after diagnosis, with the values
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Po = period from symptom onset until notification
Pd = period from laboratory diagnosis until notification
IP = incubation period
n = total number of notifications
m = number of missing i.e. excluded notifications
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laboratories in their region. With regards methods of
reporting by physicians and laboratories, five MHS
received most reports by post, and 12 MHS received
them largely by fax. Others reported a combination of
these two methods, with telephone sometimes used in
case of urgency; seven MHS received most laboratory
reports by e-mail. For all the MHS, reports from physi-
cians came most often by post or by telephone and
rarely by e-mail.
Comparing the timeliness of a total of 1533 HBV
infection reports to MHS in 2008, with respect to the
presence or absence of physician laboratory agreements,
MHS with agreements showed a significant reduction in
notification time by 5.3 days (p < 0.01; 95% CI 1.7-8.9
days), compared to MHS without agreements.
MHS, which received most reports by fax, showed an
average improvement in notification time of 3.3 days (p
< 0.05; 95% CI 0.5-6.1 days) compared to MHS which
received reports by post. E-mail was slower than fax,
though not significantly, and showed no significant
improvement compared to post.
Most MHS received about five to ten report cards per
week. Only one MHS indicated that it still received 10-
20 report cards per week from physicians, and its aver-
age Pd of notifications showed a significant delay of 19,1
days compared to the other MHS with an average Pd of
7,3 days. No MHS received more than 20 report cards
per week.
No MHS received a majority of notifications by e-
mail. Most MHS that used e-mail had encountered pro-
blems with the security of their inhouse electronic mail
system. Moreover, to protect patient privacy, an e-mail
report would often contain a minimum of information,
requiring a public health officer to spend time contact-
ing the laboratory or physician to complete the report.
Discussion
This is the first study conducted in the Netherlands on
the timeliness of infectious disease reporting at the
national level. Our key measures were the intervals
between onset of symptoms and MHS notification, and
between laboratory diagnosis and notification.
It is preferable for notification to the MHS to occur
within the incubation period to prevent transmission
leading to secondary cases. The interval after diagnosis
can be influenced by faster reporting procedures.
We found that even in this small and highly industria-
lised country, during the period studied, a considerable
number of infectious disease cases were not reported to
the Municipal Health Service (MHS) within the time
frame of two incubation periods, and many cases were
Table 2 Percentage of notifications within one and two intervals corrected for the period of infectiousness before
disease onset (Ic) for measles and hepatitis A virus infections, with the percentage assuming zero delay in laboratory
reporting (underlined percentages in italics)
percentage notifications ≤ 1 Ic (%) percentage notifications ≤ 2 Ic (%) m
Measles
(Ic 7 days) n=134
48.5 60.4 71.6 73.9 0
HAV infection (Ic 14 days) n=1518 71.4 78.7 90.3 93.1 65
Ic (interval corrected) = LP (latent period)-× (period of infectiousness in index patient preceding symptom onset)
[ ]= total number of notifications
m = number of missing i.e. excluded notifications
Table 3 Mean reporting time intervals from symptom onset and from diagnosis until notification (Po and Pd) for
infectious disease notifications per year for shigellosis and hepatitis A virus infection
Shigellosis Hepatitis A virus infection
Po (days ) 95% CI n Pd (days) 95% CI n Po (days) 95% CI n Pd (days) 95% CI n
2003 21.2 18.2-24.1 189 4.4 3.6-5.2 189 12.5 11.1-13.8 249 2.7 2.1-3.3 258
2004 21.7 18.9-24.6 336 4.5 3.8-5.1 339 14.5 12.3-16.6 420 3.8 2.4-5.1 439
2005 20.0 17.9-22.1 388 4.0 3.4-4.7 388 15.2 12.2-18.2 202 3.0 1.5-4.6 212
2006 22.2 19.0-25.4 238 3.8 3.1-4.5 239 15.1 13.2-16.9 261 2.4 1.5-3.3 277
2007 19.9 18.1-21.6 382 4.1 3.4-4.8 383 13.2 11.1-15.3 153 1.7 1.0-2.4 157
2008 21.3 18.3-24.3 372 2.9 2.5-3.2 372* 14.1 11.3-16.9 168 1.7 1.3-2.2 174
Po = period from symptom onset until notification
Pd = period from laboratory diagnosis until notification
* p < 0.05 for 2008 versus 2003 and 2004
n = number of notifications
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mation of diagnosis. This striking delay in reporting
leads to considerable delay of response measures by the
MHS and the National Institute for Public Health and
the Environment (RIVM). Differences in timeliness of
reporting for each disease cannot only be attributed to
differences in incubation periods. Cases of measles and
typhoid fever, as well as cases of meningococcal disease
and EHEC/STEC infections, show different percentages,
despite their incubation periods being very similar. We
find that each disease has specific attributes that have to
be analysed for each step in the surveillance process in
order to identify reasons for delays and to find options
for improvement [4,7].
Shigellosis and EHEC/STEC infections have short
incubation periods and require time-consuming labora-
tory testing for diagnosis. These two disease categories
consequently show remarkable delays in reporting; for
shigellosis, we found even higher percentages of delay
than were found in other studies [6-8]. We hypothesise
that shigellosis patients in the Netherlands present to
their general practitioner at a later stage of the disease
than patients in other countries, and that laboratory
diagnosis is likewise requested at a later stage. However,
we were not able to investigate these hypotheses. We
did find that physicians and laboratories are not aware
of the importance of rapidly reporting these cases, lead-
ing to an increase in the percentage of shigellosis and
EHEC/STEC infections that are reported more than
three days after diagnosis. This may be a cause for con-
cern as has been found in other studies [18]. Public
health response measures, such as improving hygiene
and implementing fast exclusion policies in schools or
institutions, are sometimes urgently required in order to
avoid outbreaks of these two diseases. We must there-
fore conclude that Dutch surveillance is not sufficient
with regard to these infections, and that additional
approaches to control, such as public education on
hygiene and raised awareness of urgency among physi-
cians, must be considered.
The severity of illness of meningococcal disease gener-
ally creates a sense of urgency for the diagnosing physi-
cian, which no doubt extends to reporting.
Chemoprophylaxis, preferably administered within 24
hours after identification of the index case, is the pri-
mary means for preventing meningococcosis, and the
ability of health services to identify contacts in time,
depends largely on timeliness of reporting. Nevertheless,
we found that 13.3% of cases of meningococcosis are
not reported within two incubation periods, a total of
seven days. Other studies have likewise found subopti-
mal timeliness of reporting cases of this disease [9,10].
Optimising Pd, as shown in Table 1, by immediate
laboratory reporting, can make an essential improve-
ment and should be applied.
Using the time interval corrected for infectiousness
before disease onset (Ic), we found that even diseases
with longer incubation periods (measles, HAV infection)
have a considerable percentage of cases notified after
one Ic. Although overall vaccination coverage for
measles is high in the Netherlands, unvaccinated sub-
groups persist. It is therefore cause for concern that
51.5% of cases are not notified within one Ic. For
measles, a rapid vaccination campaign for contacts of
infectious cases is essential for controlling an outbreak.
HAV infections occasionally cause outbreaks in the
Netherlands in child day-care centres, schools, or other
institutions. Most of these outbreaks are initiated by
children of immigrants, who become infected when tra-
velling to their parents’ home countries [19]. The effec-
tiveness of active or passive immunisation of contacts in
preventing illness depends on the time elapsed after
HAV exposure. Since HAV infections have a long incu-
bation period, it is acceptable that 90.3% of cases are
reported within one incubation period. However, the
percentage of cases reported within one Ic should be
improved.
Given that direct laboratory reporting can reduce
delays, Dutch legislation was introduced in December
2008 to make laboratory reporting mandatory in addi-
tion to the mandatory reporting by physicians. This
could considerably improve the reporting speed for
MHS lacking physician agreements, an assumption that
we will analyse in the coming years.
The findings of the present study are subject to some
limitations. Several MHS merged during the study per-
iod, causing some loss of data from former MHS. Also,
many MHS, especially those serving large cities, receive
reports from several laboratories but do not have physi-
cian agreements covering all of them, impeding a com-
parison of laboratories. However, our findings are
supported by other studies in the Netherlands that deal
with physician-laboratory-MHS agreements [14].
Many cases of measles are reported solely on the basis
of epidemiological criteria (i.e. a clinical case definition
combined with known exposure to someone with a
laboratory confirmed diagnosis) and need no laboratory
confirmation. As there is no laboratory-related delay in
such cases, the over all median Po may be shorter for
measles. For the other diseases we studied, the propor-
tion of cases reported solely on the basis of epidemiolo-
gical criteria, is negligible.
In assessing the report cards posted by physicians to
their MHS, we used the absolute number of cards and
did not correct for variation in MHS region size. How-
ever, the MHS that received the most cards is not
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ber of notifications is in the mid-range.
For all six of the infectious diseases considered, we
have demonstrated how much timeliness in notification
could be improved if MHS were to receive reports from
physicians on the day of laboratory diagnosis (assuming
that Pd is zero), thereby shortening Po. Although the Pd
will not be zero for cases diagnosed on weekend days,
this does not detract from the possible improvement
during working days, when most cases are diagnosed.
Agreements between physicians and laboratories that
allow direct laboratory reporting can reduce delay by
several days, and fast communication methods such as
fax or telephone are preferable to post.
However, the results of the means of the Po per year,
did not show an improvement for shigellosis or HAV
infection, while the means of the Pd decreased by one
day (statistically significant only for shigellosis). Appar-
ently, a one day decrease in the Pd is not significant
enough to result in a difference in the means of the
total time delay. Nonetheless, the median values and
percentages of infections reported within the incubation
period do show a clear improvement by direct reporting.
Interestingly, the use of e-mail by reporting physicians
or laboratories does not seem to accelerate the process,
largely due to security problems.
Some countries have experienced improvement of
timeliness through direct and automated electronic
laboratory reporting (ELR) [20-24]. Such systems allow
physicians to report over the internet (using web forms),
and data can even be imported from the laboratory
computer systems, eliminating manual data entry.
Reporting methods and procedures should be optimised
in the Netherlands, for example, by developing more
secure e-mail approaches, adjusted web forms for
reporting, or automated ELR.
In this study we chose to compare median incubation
periods with median notification times as a measure of
timeliness. However, this comparison has two major
shortcomings. One is that incubation time measures the
time between infection and appearance of symptoms,
but not the time to infectiousness and further transmis-
sion. With diseases in which onward transmission
occurs before symptoms appear, the latent period is a
better measure of timeliness. Therefore we introduced
the period Ic for HAV infection and measles as measure
of timeliness instead of the incubation period. It follows
that the optimal way to define timeliness would be to
base it on the generation interval, i.e. the time between
infection of the index case and infection of its secondary
case. However, as the generation interval is difficult to
observe the serial interval is usually used, i.e. the
expected time between symptom onset in the index case
and symptom onset in its secondary case [11,17].
The second problem in measuring timeliness is that
intervals for notification and latent periods are not fixed
but distributed, possibly with a large variance.
In Figure 3, it is readily noticeable that for shigellosis,
a disease with a very short incubation time (low var-
iance), the distribution of the reporting time lies far
beyond this incubation interval and has a large variance.
In contrast, for HAV infection the curves are more
alike, showing a large proportion of cases within the
incubation period.
A comprehensive analysis requires taking into account
the distribution of notification time intervals and com-
paring it to the distribution of generation times. We are
Figure 3 Distributions of the incubation period (pink curves)
and reporting time (grey curves), with their median values
(lines), of shigellosis, hepatitis A virus infection, and typhoid
fever cases.
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the distributional properties of the relevant time
intervals.
Conclusions
In recent years in the Netherlands, a disappointingly large
number infectious disease cases have not been reported
within the incubation period, especially when the incuba-
tion period is short and laboratory testing is time-consum-
ing, resulting in a considerable delay of response
measures. For shigellosis and EHEC/STEC infections,
additional control measures may therefore be necessary.
Even for diseases with long incubation periods, such
as measles and HAV infection, a considerable percen-
tage has been reported after a time interval corrected
for the period of infectiousness before disease onset (Ic).
Delays in patient presentation or in performance of
laboratory testing can cause unavoidable delays in MHS
notification. However, delay after laboratory diagnosis
can be minimised by optimising reporting procedures
and using fast communication methods. We show that
in the Netherlands, the use of adjusted web forms for
reporting or of automated laboratory reporting systems
have yet to be explored.
Whatever the systems used, evaluating the time inter-
vals of reporting for each infectious disease must be an
ongoing process, and the development of international
standardised methods to measure timeliness needs to be
promoted.
The use of intervals such as latent period and genera-
tion time and the distributions of those intervals may
allow better study of the concept of timeliness in infec-
tious disease surveillance systems.
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